In an update to its Influenza Risk Assessment Tool (IRAT), the US Centers for Disease Control and Prevention (CDC) yesterday added 2 more viruses, raising the total on the list to 15.
In the children's study, headache, irritability, and hospitalization rates varied by age.
Authorities in a second Indian state are investigating two suspected Nipah virus infections, both of them in people who had traveled to Kerala state where they had contact with infected patients, Reuters reported today, citing a health official in Karnataka state.
The US Food and Drug Administration (FDA) approved an additional claim for the cobas Zika test, manufactured by Roche Molecular Diagnostics, the company announced today in a news release. The approval allows the test to be used to screen pooled blood and plasma donations for the Zika virus.
According to Roche, the new application will streamline the screening process of multiple individual blood or plasma donations.
The extra testing cost about $42 million and identified only 9 positive donations.
Tick-borne diseases more than doubled and account for more than 60% of all vector-borne infections.
A state-by-state analysis of global health spending published today estimates that US government investments bring jobs, health security, and an economic boost to state economies while saving millions of lives worldwide, according to a report by the Global Health Technologies Coalition (GHTC).
Also, in a study involving macaques, Zika virus caused fetal death, and monoclonal antibodies proved ineffective.
Infectious virus was found in 3 of 78 samples, all within 30 days of illness onset.
The pace of new infections in Nigeria's Lassa fever outbreak is starting to slow, but the epidemic is far from contained, the World Health Organization (WHO) and the Nigeria Centre for Disease Control (NCDC) said yesterday in a statement.